Meeting the Needs of the Patient and End Consumer

Lonza took a major step towards advancing our strategy of being the world’s leading, integrated, value-added solutions provider along the healthcare continuum with the acquisition of Capsugel in 2017. An innovative global supplier of oral, nasal and other dosage forms for medicines, nutritional supplements and consumer healthcare products, Capsugel brings to Lonza a trusted brand with a large breadth of technologies. Capsugel's products and services have expanded the market reach of our contract development and manufacturing organization and products businesses. It will also support Lonza’s strategic ambition of getting closer to the patient and end consumer.  

Now we are able to serve the entire Healthcare Continuum and build on our legacy of being one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology

With more than a century of experience, we have a unique capability to connect our biotech expertise with our fine chemical know-how to help our customers meet some of the world’s greatest challenges. These Global Megatrends include the universal desire for disease prevention and treatment, clean water, healthful food, enhanced hygiene, personal well-being and energy conservation.

To satisfy these escalating needs, both the Pharma&Biotech and Specialty Ingredients segments excel at consistently delivering high-quality products, providing tailored technical and regulatory support, and offering a broad portfolio of registered and approved actives that meet the world's most exacting regulatory standards

Read more about how Lonza is addressing Global Megatrends and patient and consumer needs all along the Healthcare Continuum.